The Claim
Selenium supplementation in patients with Graves' disease does not produce sustained clinical benefit, as biochemical markers including FT3, FT4, TSH, and TRAb revert to baseline levels by 9 months despite ongoing supplementation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking selenium supplements does not keep thyroid hormone levels improved in people with Graves' disease beyond six months; after nine months, these levels return to what they were before treatment, even if supplementation continues.
See the scientific wording
Selenium supplementation does not demonstrate sustained clinical benefit in Graves' disease beyond 6 months, as biochemical improvements in FT3, FT4, TSH, and TRAb levels revert to baseline by 9 months despite continued supplementation.
What the research says
1 studyStudy: Effects of Selenium Supplementation on Graves' Disease: A Systematic Review and Meta-Analysis
Taking selenium helps improve thyroid blood markers in Graves' disease for up to 6 months, but after 9 months, those improvements disappear even if people keep taking it. So, selenium doesn't work long-term.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.